UTime Limited announces an ambitious strategy and strategic collaboration in AI-enabled health technology
Thursday, August 22, 2024
UTime Limited, is pleased to announce its ambitious strategy to develop artificial intelligence-enabled healthcare solutions. Recognizing the growing value and potential of smart healthcare technology, UTime is making significant investments to expand its smart wearable healthcare business.
As part of strategic cooperation with Dr. With Ehud Baron, a recognized figure in medical technology innovation, UTime is set to expand its blood pressure measurement offering to include hemodynamic measurement and health monitoring products. Dr. Baron will work with the UTime team to develop comprehensive plans for diverse healthcare product lines. It will initially focus on optimizing UTime's flagship blood pressure watch. After successful development, the company plans to further expand its product range to meet a wide range of smart healthcare needs of its customers.
In addition, UTime plans to launch a range of products aimed at intelligently detecting key health indicators, such as heart rate and sleep trackers.
Hengcong Qiu, Chairman of UTime, said: “We believe that our strategic collaboration with Dr. Ehud Baron and our AI-based healthcare initiatives will represent key growth opportunities for UTime and position us at the forefront of health technology innovation."
About UTime Limited
UTime Ltd. was founded in 2008 and provides affordable mobile devices to consumers around the world and helps low-income groups in established markets, including the United States, as well as emerging markets, gain better access to the latest mobile technologies. In 2024, UTime is committed to transforming health and wellness through innovative medical wearables. By leveraging cutting-edge research and strategic partnerships, UTime strives to provide effective disease prevention solutions on a global scale. For more information, visit the company's website at http://www.utimeworld.com/ .
Forward-looking statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's continuing listing requirements. The words "expect," "believe," "continue," "could," "estimate," "expect," "intend," " may", "plan", "potential", "anticipate", "project", "should", "target", "will", "should" and similar expressions indicate that these are forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those expressed in these forward-looking statements as a result of various important factors set forth in the "Risk Factors" section of the Annual Report on Form 20-F filed with the Securities and Exchange Commission on December 30. July 2024. All forward-looking statements contained in this press release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information contact:
Eaky Tan
eaky@westock.com
Source: prnewswire.com